Core 1: Clinicopathological Analysis and Disease Modeling
Core 1: Clinicopathological Analysis and Disease Modeling
批准号:
10705098
负责人:
Iman Osman
金额:
$26.09万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-15 至 2027-07-31
关键词:
AmericanAnimal ModelArtificial IntelligenceAwardBiologicalClinicalCollaborationsDataDisease modelEnsureGenerationsGenetic EngineeringGoalsHealthHumanHuman ResourcesImaging technologyImmunofluorescence ImmunologicInstitutionInternationalLinkMissionModelingMolecularMusNeoplasm MetastasisNew YorkPathogenicityPathologicPathologistPathologyPatientsPilot ProjectsProcessQuality ControlResearchResearch InfrastructureResearch Project GrantsResourcesRoleSamplingServicesSocietiesTechnologyTestingTranslational ResearchUniversitiesValidationWorkXenograft procedureanimal tissuecancer typecollegecommunity centercost effectivecost effectivenessdigitalhuman tissueinnovationmelanomamembermouse modelnew technologynovelprogramsprospectiverepositorysuccesstranscriptomicstumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CLINICOPATHOLOGICAL ANALYSIS AND DISEASE MODELING CORE SUMMARY
The primary objective of the Clinicopathological Analysis and Disease Modeling Core (Core B) is to catalyze the
New York University Langone Health (NYULH) Metastasis Research Network Center’s research goals by
providing high-quality, clinically annotated melanoma biospecimens, expertise in human and animal tissue
analyses, and cutting-edge technological resources.
To execute the central scientific strategy of the NYULH Metastasis Research Network Center, Core B will 1)
procure both retrospective and prospective melanoma patient samples needed for cross-validation of murine
data and hypothesis generation for animal model testing, 2) refine cutting-edge imaging technologies for
multispectral immunofluorescence analyses, and 3) provide expertise in the pathological assessment of post-
experimental mouse and human tissues to support the 3 main projects as well as pilot projects. Through a
governance committee, Core B will also provide oversight of biospecimen use. Leveraging the resources of
NYULH Melanoma Program including the recently awarded SPORE, Core B will serve both the NYULH
Metastasis Research Network Center community as well as other Centers of the Network, avoiding duplication
of efforts and maximizing cost-effectiveness and efficiency.
Overall, Core B will provide high quality, annotated melanoma patient biospecimens, cutting-edge technological
resources, and pathological expertise to all Center studies to support the NYULH Metastasis Research Network
Center’s mission to uncover determinants of melanoma metastasis, focused on drivers of early dissemination
and cross-talk with micro-environmental components.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 1: Clinicopathological Analysis and Disease Modeling
-
批准号:10414447
-
项目类别:
-
资助金额:$26.65万
-
财政年份:2022
-
负责人:Iman Osman
-
依托单位:
Novel targets of treatment for NF1-mutant melanoma
-
批准号:10460574
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2021
-
负责人:Iman Osman
-
依托单位:
Novel targets of treatment for NF1-mutant melanoma
-
批准号:10289966
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2021
-
负责人:Iman Osman
-
依托单位:
Admin Core
-
批准号:10200697
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2019
-
负责人:Iman Osman
-
依托单位:
Core B - Biospecimen/Pathology Core
-
批准号:10200698
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2019
-
负责人:Iman Osman
-
依托单位:
NYU Melanoma SPORE
-
批准号:10652334
-
项目类别:
-
资助金额:$208.42万
-
财政年份:2019
-
负责人:Iman Osman
-
依托单位:
Core B - Biospecimen/Pathology Core
-
批准号:10652337
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2019
-
负责人:Iman Osman
-
依托单位:
Admin Core
-
批准号:10652335
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2019
-
负责人:Iman Osman
-
依托单位:
Core B - Biospecimen/Pathology Core
-
批准号:10434085
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2019
-
负责人:Iman Osman
-
依托单位:
NYU Melanoma SPORE
-
批准号:10200696
-
项目类别:
-
资助金额:$206.52万
-
财政年份:2019
-
负责人:Iman Osman
-
依托单位:
NYU Melanoma SPORE
-
批准号:9980824
-
项目类别:
-
资助金额:$210.91万
-
财政年份:2019
-
负责人:Iman Osman
-
依托单位:
NYU Melanoma SPORE
-
批准号:10434082
-
项目类别:
-
资助金额:$203.52万
-
财政年份:2019
-
负责人:Iman Osman
-
依托单位:
Admin Core
-
批准号:10434083
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2019
-
负责人:Iman Osman
-
依托单位:
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
-
批准号:10469478
-
项目类别:
-
资助金额:$36.07万
-
财政年份:2018
-
负责人:Iman Osman
-
依托单位:
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
-
批准号:10241380
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2018
-
负责人:Iman Osman
-
依托单位:
Development of a new treatment modality for melanoma brain metastases - Resubmission - 1
-
批准号:8880582
-
项目类别:
-
资助金额:$20.34万
-
财政年份:2015
-
负责人:Iman Osman
-
依托单位:
Clin.Relevance of Circulat.Tumor Cells in Bladder Cancer
-
批准号:6744765
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2003
-
负责人:Iman Osman
-
依托单位:
Clin.Relevance of Circulat.Tumor Cells in Bladder Cancer
-
批准号:6602044
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2003
-
负责人:Iman Osman
-
依托单位:
Melanoma (MEL) Research Program
-
批准号:10358554
-
项目类别:
-
资助金额:$3.28万
-
财政年份:1997
-
负责人:Iman Osman
-
依托单位:
Melanoma (MEL) Research Program
-
批准号:10609011
-
项目类别:
-
资助金额:$3.28万
-
财政年份:1997
-
负责人:Iman Osman
-
依托单位:
海外基金